NCT05473949View on ClinicalTrials.gov

Ketofol Versus Propofol for Sedation in Cholangiopancreatography for ASA III and ASA IV Patients.

NACompletedINTERVENTIONAL
Enrollment

102

Participants

Timeline

Start Date

October 1, 2016

Primary Completion Date

March 31, 2017

Study Completion Date

March 31, 2017

Conditions
Anesthesia
Interventions
DRUG

Profofol for Sedation in Cholangiopancreatography for ASA III and ASA IV Patients

Use of 1% Propofol (Indution dose: 0.75mg/kg Maintenance dose: 6-7mg/kg/h) for Sedation in Cholangiopancreatography for ASA III and ASA IV Patients

DRUG

Ketofol for Sedation in Cholangiopancreatography for ASA III and ASA IV Patients

use of Ketofol (1% Propofol + 5% Ketamine with a ratio 1/4) Indution dose: 0.75mg/kg Maintenance dose: 6-7mg/kg/h) for Sedation in Cholangiopancreatography for ASA III and ASA IV Patients

All Listed Sponsors
lead

Centro Hospitalar Universitário Lisboa Norte

OTHER

NCT05473949 - Ketofol Versus Propofol for Sedation in Cholangiopancreatography for ASA III and ASA IV Patients. | Biotech Hunter | Biotech Hunter